Rather than grimly assembling data about cancer deaths to predict outcomes in treatment, the founders of Cure51 had another idea.
The biotech startup's $6.5 million seed round is led by VC firm NFX but it is perhaps equally noteworthy to see that Merck is also participating in the round.
For this edition of Pitch Deck Teardown, we're taking a close look at the CancerVAX campaign on the equity crowdfunding platform, StartEngine.
California-based startup Mission Bio has raised a new $70 million Series C funding round, led by Novo Growth and including participation from Soleus Capital and existing investors Mayfield, Cota and A
Spotting and diagnosing cancer is a complex and difficult process even for the dedicated medical professionals who do it for a living. A new tool from Google researchers could improve the process by p
Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can creat
Roughly 600,000 people in China die from lung cancer every year. The issue is compounded by a lack of quality healthcare in much of the country, which means that cancers often go undetected until it's
A New York City startup called The Mednet today launched a platform that gives physicians a knowledge-sharing tool that’s as easy to use as Quora, but provides them with expert answers about the lat
Y Combinator-backed biotech company Bikanta wants to find and stop cancer at its source by inserting tiny, fluorescent diamonds inside your body. The brainchild of Dr. Ambika Bumb, who holds a PhD in